The Method Development Qualification & Validation (Part of Biotherapeutics Analytical Summit 2018) covers topics such as:
MAM Method Development and Qualification
Regulatory Perspectives on Analytical Method Validation and Transfer for Biopharmaceutical ProductsSubvisible Particle Analysis: New Tools and Potential Opportunities
Development and Implementation of High-Throughput Assays to Support Process Development
Analytical Method Replacement Strategies and Case Studies for Late-Stage Development and Approved Products
Developing an Analytical Platform for an Accelerated Vaccine Program
ADC Method Development and Validation Strategies
Development and Qualification of an Activity Assay Using a Physiologically Relevant Substrate
Application of Design of Experiment (DOE) in Analytical Method Development
The Impact of Excess Antigen and Non-Linearity of Dilution on Host Cell Protein Immunoassay Development and Qualification
Development and Qualification of a Novel Cell-Based Assay for Therapeutic mAb against Viral Infection
Past Events
Method Development Qualification & Validation (Part of Biotherapeutics Analytical Summit 2018) - 12-13 Mar 2018, Sheraton Inner Harbor Hotel, Baltimore, Maryland, United States (73645)
Important
Please, check "Method Development Qualification & Validation (Part of Biotherapeutics Analytical Summit)" official website for possible changes, before making any traveling arrangements
